Sol-Gel Technologies (SLGL) Payables (2016 - 2026)
Sol-Gel Technologies (SLGL) posted quarterly Payables of $782000.0 for Q1 2026, up 78.54% year-over-year from $438000.0 in Q1 2025, and up 6.39% quarter-over-quarter from $735000.0 in Q4 2025.
Powered by 
Analysis
Sol-Gel Technologies (SLGL) Payables (2016 - 2026) Analysis & Trends
Sol-Gel Technologies (SLGL) has reported Payables for 11 consecutive years, with $782000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Payables rose 78.54% year-over-year to $782000.0; the TTM figure through Mar 2026 stood at $782000.0 (up 78.54% YoY), while the FY2025 annual figure was $735000.0, down 79.53% from the prior year.
- Payables advanced to $782000.0 in Q1 2026 per SLGL's latest filing, from $735000.0 in the prior quarter.
- Across five years, Payables topped out at $3.9 million in Q4 2023 and bottomed at $167000.0 in Q3 2022.
- Historically, Payables has averaged $1.0 million across 5 years, with a median of $735000.0 in 2025.
- Annual changes were most pronounced in 2022 — Payables slumped 97.53% — and 2023, when it soared 1462.15%.
- Sol-Gel Technologies' Payables stood at $251000.0 in 2022, then jumped by 1462.15% to $3.9 million in 2023, then retreated by 8.44% to $3.6 million in 2024, then sank by 79.53% to $735000.0 in 2025, then rose by 6.39% to $782000.0 in 2026.
- Business Quant data shows SLGL's Payables at $782000.0 in Q1 2026, $735000.0 in Q4 2025, and $828000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 167.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 88.42 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 470.30 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 108.02 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 35.57 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Sol-Gel Technologies | 194.01 Mn | 146.08 Mn | - | 3.50 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.50 Mn |
| Mar 31, 2026 | 5.05 Mn |
| Dec 31, 2025 | 4.94 Mn |
| Sep 30, 2025 | 4.83 Mn |
| Jun 30, 2025 | 3.31 Mn |
| Mar 31, 2025 | 3.70 Mn |
| Dec 31, 2024 | 3.59 Mn |
| Sep 30, 2024 | 4.63 Mn |
| Jun 30, 2024 | 679,000.00 |
| Mar 31, 2024 | 4.26 Mn |
| Dec 31, 2023 | 3.92 Mn |
| Sep 30, 2023 | 3.81 Mn |
| Jun 30, 2023 | 4.77 Mn |
| Mar 31, 2023 | 3.04 Mn |
| Dec 31, 2022 | 2.36 Mn |
| Sep 30, 2022 | 1.74 Mn |
| Jun 30, 2022 | 1.66 Mn |
| Mar 31, 2022 | 2.34 Mn |
| Dec 31, 2021 | 10.15 Mn |
| Sep 30, 2021 | 2.34 Mn |